Novavax (NVAX) and Serum Institute of India Announce Submission to Regulatory Agencies in India, Indonesia, Philippines for Emergency Use Authorization of Novavax' Recombinant Nanoparticle COVID-19 Va
Go back to Novavax (NVAX) and Serum Institute of India Announce Submission to Regulatory Agencies in India, Indonesia, Philippines for Emergency Use Authorization of Novavax' Recombinant Nanoparticle COVID-19 Va| Novavax, Inc. (NASDAQ: NVAX) | Delayed: 8.88 -0.15 (1.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.03 | 52 Week High | $9.23 | |||
| Open | $9.07 | 52 Week Low | $1.16 | |||
| Day High | $9.30 | P/E | N/A | |||
| Day Low | $8.80 | EPS | $-0.30 | |||
| Volume | 2,591,783 | |||||
